PacBio Stock Up on Q2 Earnings & Revenue Beat Estimates, Margin Rises
PACB stock jumps after Q2 results beat estimates, with narrow losses, rising margins, and strong global demand.
Pacific Biosciences of California ( PACB ) Reports Q2 Loss, Beats Revenue Estimates
Pacific Biosciences (PACB) delivered earnings and revenue surprises of +27.78% and +9.06%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Tandem Diabetes Care, Inc. ( TNDM ) Reports Q2 Loss, Beats Revenue Estimates
Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of -20.00% and +0.87%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Stay Ahead of the Game With Pacific Biosciences ( PACB ) Q2 Earnings: Wall Street's Insights on Key Metrics
Beyond analysts' top-and-bottom-line estimates for Pacific Biosciences (PACB), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
Pacific Biosciences of California ( PACB ) Suffers a Larger Drop Than the General Market: Key Insights
Pacific Biosciences of California (PACB) reached $1.54 at the closing of the latest trading day, reflecting a -6.1% change compared to its last close.
Pacific Biosciences of California ( PACB ) Stock Sinks As Market Gains: What You Should Know
Pacific Biosciences of California (PACB) reached $1.39 at the closing of the latest trading day, reflecting a -6.71% change compared to its last close.
Pacific Biosciences of California ( PACB ) Beats Stock Market Upswing: What Investors Need to Know
The latest trading day saw Pacific Biosciences of California (PACB) settling at $1.5, representing a +1.35% change from its previous close.
Here's Why You Should Add PacBio Stock to Your Portfolio Now
PACB benefits from strong first-quarter results, product innovation, and cost cuts to offset macroeconomic concerns and drive 2025 growth.
Pacific Biosciences ( PACB ) Upgraded to Strong Buy: Here's What You Should Know
Pacific Biosciences (PACB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Pacific Biosciences of California ( PACB ) Stock Sinks As Market Gains: What You Should Know
The latest trading day saw Pacific Biosciences of California (PACB) settling at $1.24, representing a -3.88% change from its previous close.
Why Is Steris ( STE ) Down 1.8% Since Last Earnings Report?
Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Pacific Biosciences of California ( PACB ) Outperforms Broader Market: What You Need to Know
Pacific Biosciences of California (PACB) closed at $1.18 in the latest trading session, marking a +1.72% move from the prior day.
Here's Why You Should Add PacBio Stock to Your Portfolio Now
PACB benefits from strong first-quarter results, product innovation, and cost cuts to offset sales cycle delays and drive 2025 growth.
All You Need to Know About Pacific Biosciences ( PACB ) Rating Upgrade to Buy
Pacific Biosciences (PACB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
PacBio Stock Down Despite Q1 Earnings & Revenue Beat Estimates
Despite strong Service and other revenues, PACB reports soft first-quarter 2025 results partly due to lower Revio system shipments.
Pacific Biosciences of California ( PACB ) Reports Q1 Loss, Tops Revenue Estimates
Pacific Biosciences (PACB) delivered earnings and revenue surprises of 21.05% and 6.15%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Cathie Wood Sells Palantir Shares Worth $2.65 Million Ahead Of Earnings, Doubles Down On This Chip Giant - Advanced Micro Devices ( NASDAQ:AMD ) , ARK Innovation ETF ( BATS:ARKK )
On Wednesday, Cathie Wood-led Ark Invest executed significant trades involving Palantir Technologies Inc. PLTR, Advanced Micro Devices Inc. AMD, and Shopify Inc. SHOP. Ark Invest made a notable move by selling shares of Palantir Technologies Inc.
Pacific Biosciences of California ( PACB ) Stock Falls Amid Market Uptick: What Investors Need to Know
In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.11, marking a -1.77% move from the previous day.
Pacific Biosciences of California ( PACB ) Flat As Market Gains: What You Should Know
In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.17, marking no change from the previous day.
Sequencing Company PacBio Cuts Costs Amid Uncertainty Around NIH Funding And New Tariffs - Pacific Biosciences ( NASDAQ:PACB )
PacBio reported $36.9 million in Q1 revenue, beating consensus, with record consumable sales and steady Revio system pull-through. Company to cut $45-$50 million in annualized costs by year-end amid NIH funding uncertainty and macroeconomic pressures. Feel unsure about the market's next move?
Simply Good Foods, Pacific Biosciences of California, Kura Sushi, Delta Air Lines And Other Big Stocks Moving Higher On Wednesday - Akso Health ( NASDAQ:AHG ) , Anglogold Ashanti ( NYSE:AU )
U.S. stocks were higher, with the Dow Jones index surging over 300 points on Wednesday. Shares of The Simply Good Foods Company SMPL rose sharply during Wednesday's session following better-than-expected quarterly results.
Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen - Absci ( NASDAQ:ABSI ) , Amgen ( NASDAQ:AMGN )
On Friday, March 21, 2025, the Cathie Wood-led Ark Invest made some notable trades, including significant buys and sells. Ark Invest's fund bought Iridium Communications Inc. IRDM, Beam Therapeutics Inc. BEAM, Pacific Biosciences of California Inc. PACB and Absci Corp ABSI, while selling Illumina ...
Pacific Biosciences of California ( PACB ) Advances While Market Declines: Some Information for Investors
Pacific Biosciences of California (PACB) reachead $1.26 at the closing of the latest trading day, reflecting a +0.8% change compared to its last close.
Here's Why You Should Retain PacBio Stock in Your Portfolio Now
PACB continues to deliver growth from its unique technologies amid macroeconomic concerns.
Pacific Biosciences of California ( PACB ) Increases Yet Falls Behind Market: What Investors Need to Know
In the closing of the recent trading day, Pacific Biosciences of California (PACB) stood at $1.22, denoting a +1.67% change from the preceding trading day.
Goodyear Tire & Rubber Posts Upbeat Results, Joins Nu Skin, Pacific Biosciences of California, Airbnb, Roku And Other Big Stocks Moving Higher On Friday - Beam Therapeutics ( NASDAQ:BEAM ) , Airbnb ( NASDAQ:ABNB )
U.S. stocks were mostly lower, with the Dow Jones falling around 100 points on Friday. Shares of The Goodyear Tire & Rubber Company GT rose sharply during Friday's session after the company reported better-than-expected quarterly financial results.
PACB Stock Down Following In-Line Q4 Earnings, Revio Shipments Fall
Despite strong Service and other revenues, PacBio reports soft fourth-quarter 2024 results partly due to lower Revio system shipments.
Pacific Biosciences of California ( PACB ) Reports Q4 Loss, Tops Revenue Estimates
Pacific Biosciences (PACB) delivered earnings and revenue surprises of 0% and 0.06%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Pacific Biosciences of California ( PACB ) Stock Sinks As Market Gains: Here's Why
The latest trading day saw Pacific Biosciences of California (PACB) settling at $1.44, representing a -1.37% change from its previous close.
PacBio Announces Appointment of David Ruggiero as Head of Global Sales & Service
MENLO PARK, Calif., Feb. 03, 2025 ( GLOBE NEWSWIRE ) -- PacBio ( NASDAQ: PACB ) , a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of David Ruggiero as the company's new Global Head of Sales & Service.
PacBio Announces Appointment of David Ruggiero as Head of Global Sales & Service - Pacific Biosciences ( NASDAQ:PACB )
MENLO PARK, Calif., Feb. 03, 2025 ( GLOBE NEWSWIRE ) -- PacBio PACB, a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of David Ruggiero as the company's new Global Head of Sales & Service.
Pacific Biosciences of California ( PACB ) Stock Moves -1.18%: What You Should Know
Pacific Biosciences of California (PACB) closed at $1.67 in the latest trading session, marking a -1.18% move from the prior day.
Here's Why You Should Retain PacBio Stock in Your Portfolio for Now
PACB continues to deliver growth from its unique technologies amid business seasonality concerns.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
RNA Transcriptome Profiling Tests Market Expands at 14.5% CAGR, Surpassing US$ 37 Billion by 2034 | Fact.MR Report
Rockville, MD, Jan. 20, 2025 ( GLOBE NEWSWIRE ) -- According to Fact.MR, a market research and competitive intelligence provider, the global RNA transcriptome profiling test market is estimated to reach a valuation of US$ 9,652.2 million in 2024 and is expected to grow at a CAGR of 14.5% during ...
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
PACB Stock Declines Despite Promising HiFi Sequencing Findings
PacBio announces positive study results for HiFi long-read sequencing technology in identifying genetic causes of rare diseases.
PACB Stock Falls on Preliminary Q4 Sales Miss, 7 Vega Systems Shipped
PacBio reports dismal preliminary fourth-quarter 2024 results, caused by lower instrument. New launches and clinical focus set the stage for market growth in 2025.
PacBio Stock May Gain Following the Collaborated Launch of GutID
PACB and Intus Bio collaborate to launch GutID, the first commercial human gut health test.
PACB Stock Rises After the Shipment of Vega Systems to Berry Genomics
PacBio delivers the first Vega systems to Berry Genomics to develop and optimize its targeted assays to support screening programs in China and other markets.
Cathie Wood's Tuesday Double Dump: Ark Invest Trims Both Palantir And Bitcoin ETF Holdings - ARK 21Shares Bitcoin ETF Common Shares of Beneficial Interests ( BATS:ARKB )
On Tuesday, Cathie Wood-led Ark Invest made some significant adjustments to its portfolio. The most notable of these was the sale of shares in Palantir Technologies Inc PLTR across multiple ETFs, coupled with a substantial sale of ARK 21Shares Bitcoin ETF ARKB.
Why the Market Dipped But Pacific Biosciences of California ( PACB ) Gained Today
Pacific Biosciences of California (PACB) closed at $2 in the latest trading session, marking a +0.5% move from the prior day.
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
With Ark Invest ending 2024 on a strong note, the aggressive growth icon is hoping to build on that momentum in 2025.
Cathie Wood's Monday Moves: Dumps $15M Worth Of Hot Stock Palantir, Loads Up Amazon.com - ARK Fintech Innovation ETF ( ARCA:ARKF ) , Amazon.com ( NASDAQ:AMZN )
On Monday, Cathie Wood-led Ark Invest made notable trades involving Palantir Technologies Inc. PLTR. and Amazon.com Inc. AMZN.
Cathie Wood's Ark Dumps Coinbase Stock Amid Bitcoin Highs, Shopify Holdings Also Cut - ARK Fintech Innovation ETF ( ARCA:ARKF )
On Tuesday, Cathie Wood-led Ark Invest made significant trades involving Coinbase Global Inc. COIN and Shopify Inc. SHOP. The investment firm reduced its holdings in both companies. Ark Invest sold 5,646 shares of Coinbase Global Inc. through its Ark Fintech Innovation ETF ARKF on Tuesday.
Reasons to Retain PacBio Stock in Your Portfolio for Now
PACB continues to deliver growth from its unique technologies amid business seasonality concerns.
Cathie Wood's Ark Invest Bets Big On Biotech Again As Pacific Biosciences Grabs Spotlight - Pacific Biosciences ( NASDAQ:PACB )
Ark Invest CEO Cathie Wood is doubling down on genomics. What Happened: Pacific Biosciences of California Inc. PACB, known as PacBio, is biotech's new kid on the block. The company's Vega sequencer might be the spark that reignites the genomics flame in Ark Invest's portfolios.
Cathie Wood's Ark Invest Bets Big On Biotech Again As Pacific Biosciences Grabs Spotlight - Pacific Biosciences ( NASDAQ:PACB )
Ark Invest CEO Cathie Wood is doubling down on genomics. What Happened: Pacific Biosciences of California Inc. PACB, known as PacBio, is biotech's new kid on the block. The company's Vega sequencer might be the spark that reignites the genomics flame in Ark Invest's portfolios.
Cathie Wood's Monday Moves: $4.8M Spotify Stock Sale Meets $4.7M Pinterest Shopping Spree - ARK Fintech Innovation ETF ( ARCA:ARKF ) , Advanced Micro Devices ( NASDAQ:AMD )
On Monday, Cathie Wood's Ark Invest made significant moves in its portfolio, notably involving Spotify Technology SA SPOT and Pinterest Inc. PINS.
Cathie Wood Buys Amazon, AMD Stock - Trims Palantir, Block Holdings Amid AI And Bitcoin Euphoria - Advanced Micro Devices ( NASDAQ:AMD )
On Wednesday, Cathie Wood-led Ark Invest made some notable trades. The most prominent among these were in Amazon.com Inc AMZN, Advanced Micro Devices Inc. AMD, Palantir Technologies Inc. PLTR, and Block Inc. SQ.
